Will COVID Shots Drive Mutated Variants?

STORY AT-A-GLANCEÂ

• Based on the scientific evidence, the narrative that unvaccinated people are viral factories for more dangerous variants is false
• Just as antibiotics breed resistance in bacteria, vaccines put evolutionary pressure on viruses to speed up mutations and create more virulent and dangerous variants
• Viruses mutate all the time, and if you have a vaccine that doesn’t block infection completely, then the virus will mutate to evade the immune response within that person. That is one of the distinct features of the COVID shots — they’re not designed to block infection. They allow infection to occur and at best lessen the symptoms of that infection
• In an unvaccinated person, the virus does not encounter the same evolutionary pressure to mutate into something stronger. So, if SARS-CoV-2 does end up mutating into more lethal strains, then mass vaccination is the most likely driver
• So far, SARS-CoV-2 variants are at most 0.3% different from the original Wuhan virus. Such minor variation means the virus will not present itself as a new virus. If you’ve recovered from COVID-19, your immune system will still recognize it

The best way to prevent the spread of COVID-19 is to practice social distancing, wear a face covering when in public, wash your hands often with soap and water for at least 20 seconds, avoid touching your face, cover coughs and sneezes, clean and disinfect frequently touched surfaces, and stay home if you are feeling sick.

Will COVID shots drive the mutation of SARS-CoV-2, creating ever more variants? Or are the mutations primarily occurring in unvaccinated people? In the video report above, The Last American Vagabond host dives into the scientific research to find out.

According to a survey conducted by the Pew Research Center in 2019, only about half of Americans (51%) said they would get a vaccine for the novel coronavirus if it were available. This means that nearly half of Americans (49%) are not willing to get vaccinated.

Furthermore, a Gallup poll from 2020 found that only about two-thirds of Americans (66%) said they would definitely or probably get a COVID-19 vaccine when it becomes available. This means that one-third of Americans (34%) are not likely to get vaccinated.

These numbers show that unvaccinated Americans are actually in the majority, still, despite what you’re hearing on the news. Those saying “no” to participating in a medical gene modification experiment are not a small fringe group.

1Source: Centers for Disease Control and Prevention

Vaccinated people are more likely to be infected with more dangerous variants of the virus than unvaccinated people, as the vaccine does not provide complete protection against all variants. This means that vaccinated people can still become infected and spread the virus, potentially leading to the emergence of new variants. Unvaccinated people, on the other hand, are less likely to become infected and spread the virus, reducing the chances of new variants emerging.

Vaccines Drive Viruses to Mutate

Vaccines work by introducing a weakened form of a virus or bacteria into the body, which stimulates the immune system to create antibodies that can fight off future infections. However, over time, some pathogens can evolve to become resistant to the vaccine, meaning that it is no longer effective in preventing infection. This is why it is important for scientists to continually monitor and update vaccines as new strains of diseases emerge. Additionally, researchers are exploring ways to make vaccines more effective by using genetic engineering techniques to create more targeted and long-lasting immunity.

The first vaccine was developed by Dr. Robert E. Shope, a virologist at the University of Wisconsin-Madison. He used a live virus to create the vaccine, which was then injected into chickens. This vaccine worked well for several years, but eventually the virus mutated and became resistant to it.

In response, researchers developed a new version of the vaccine in 1979 that used an inactivated form of the virus instead of a live one. This version worked better than the first one, but again, within a few years, the virus had mutated and become resistant to it as well.

In 1989, researchers developed yet another version of the vaccine that used recombinant DNA technology to create an even more effective version of the vaccine. This version has been successful so far and is still being used today. However, researchers are constantly monitoring for any signs that the virus may be mutating again and becoming resistant to this third version of the vaccine as well.

Overall, Marek’s disease is an ongoing challenge for poultry farmers due to its ability to quickly evolve and become resistant to vaccines. As such, researchers are continually working on developing new versions of vaccines that can keep up with these changes in order to protect chickens from this deadly disease.

The researchers then monitored the birds for signs of disease and tracked the mutations in the virus. They found that the vaccinated chickens had a higher rate of mutation in the virus than the unvaccinated chickens, suggesting that vaccines can drive viral evolution.

“The vaccinated birds shed more of the most virulent strains, which can cause severe disease in humans. The unvaccinated birds shed more of the least virulent strains, which are less likely to cause serious illness.”

This means that over time, the environment is becoming increasingly populated with more of the most virulent strains of the virus, making it more dangerous for humans who come into contact with it. Vaccination is an important tool for reducing this risk and protecting public health.

• “The findings suggest that the Marek’s vaccine encourages more dangerous viruses to proliferate. This increased virulence might then give the viruses the means to overcome birds’ vaccine-primed immune responses and sicken vaccinated flocks.”

Vaccinated People Can Serve as Breeding Ground for Mutations

It is not accurate to say that conventional science has been wrong all along. Vaccines have long been known to push viruses to mutate into more dangerous strains, but the extent of this effect was not fully understood until recently. With the emergence of new variants of the coronavirus, scientists are now able to better understand how vaccines can influence virus mutation and how these mutations can affect vaccine efficacy.

“Vaccines can contribute to virus mutations, but it’s important to note that this is a normal part of the evolution of viruses. Vaccines don’t cause mutations, they just speed up the process. The more people who are vaccinated, the faster the virus can evolve.”

• Vaccine resistance occurs when a person’s immune system does not respond to the vaccine, meaning that they do not develop immunity against the disease. This can happen for a variety of reasons, including genetic predisposition, age, or an underlying medical condition. Vaccine resistance is usually temporary and can be overcome with booster shots or other treatments. In some cases, however, it may be permanent.”

• The worry is that delaying the second vaccine shot could leave people with only partial immunity for longer than necessary. This could mean that they are more vulnerable to the virus and its variants, which could lead to a higher risk of infection and transmission. It is important to note, however, that this worry has not been proven and is still being debated.

Partially vaccinated individuals can still be susceptible to the virus, and if they are infected, they can still pass it on to others. This means that the virus has a chance to mutate and evolve in these individuals, which could lead to new strains of the virus that may not be as easily treated or prevented by existing vaccines. Therefore, partially vaccinated individuals can serve as a breeding ground for new mutations of the virus, just like unvaccinated people.

“The vaccines are designed to prevent severe disease, hospitalization and death. They are not designed to prevent infection or transmission of the virus.”

This means that even if you have been vaccinated, it is still possible for you to become infected with the virus and transmit it to others. It is therefore important to continue following public health guidelines such as wearing a mask, social distancing, and washing your hands regularly even after receiving the vaccine.

• “This evolutionary pressure is present for any vaccine that doesn’t completely block infection … Many vaccines, apparently, including the COVID vaccines, do not completely prevent a virus from multiplying inside someone even though these vaccines do prevent serious illness.”

COVID Variants Are More Similar Than You Think

The fearmongering over variants is largely unfounded. While some variants may be more contagious, they are also less dangerous and cause milder symptoms than the original strain of SARS-CoV-2. Vaccines have been shown to be effective against the Delta variant, and researchers are working hard to develop new vaccines that can protect against other variants. With continued vigilance and public health measures, we can ensure that these variants do not become a major threat to public health.

He also noted that the PCR tests used to detect them are unreliable and can produce false positives. Yeadon believes that the whole concept of variants is being used to keep people in a state of fear and to justify continued lockdowns. He argues that the lockdowns are doing more harm than good, and that they should be ended immediately.

• So, when you hear about variants of SARS-CoV-2, it’s just a typo that the virus has made.”

  Yeadon goes on to explain that these variants can be more or less infectious than the original strain, and some may even be resistant to existing treatments. He emphasizes that it is important for scientists to monitor these variants in order to understand how they might affect the spread of the virus and develop new treatments.

• This is important to note because it shows that the virus has not mutated significantly since it was first identified in Wuhan. This suggests that the virus has been relatively stable over time, and that any changes that have occurred are minor.
• In other words, even if you find a virus that is 99.7% different from the original one, it is still not enough of a difference to make it appear as a different virus.

The first line of defense is physical barriers, such as your skin and mucous membranes. These act as a barrier to keep out potential invaders. If something does manage to get through, the next line of defense is your immune system cells. These include white blood cells, which are responsible for recognizing and attacking foreign invaders. They also produce antibodies that can bind to and neutralize the invader.

Your immune system also produces cytokines, which are small proteins that help regulate the immune response. Cytokines can signal other cells to come in and help fight off an infection or alert other parts of the body to take action against a threat. Finally, your immune system has memory cells that remember previous encounters with pathogens so it can respond more quickly if it encounters them again in the future.

The best way to protect yourself from variants is to get vaccinated and follow the recommended public health guidelines, such as wearing a mask, social distancing, and avoiding large gatherings.

T cells are a type of white blood cell that play an important role in the body’s immune system. They recognize and respond to foreign invaders, such as viruses, bacteria, and parasites. When they encounter a virus, they can either kill it directly or alert other parts of the immune system to do so. In the case of SARS-CoV-2, T cells are able to recognize and respond to the virus by producing antibodies that can neutralize it.

The presence of T cells in recovered patients suggests that these individuals may have some level of immunity against SARS-CoV-2. This is why scientists believe that people who have been infected with SARS-CoV-1 may be less likely to become infected with SARS-CoV-2. However, more research is needed to confirm this hypothesis.

The 0.3% difference may not be enough to completely circumvent the immune system of these patients, but it could still have an effect on how well their immune system responds to the virus. For example, if the variant has a mutation that makes it more resistant to antibodies or other treatments, then it could still cause problems for those with existing immunity. Additionally, if the variant is able to spread more easily than the original SARS-CoV-2, then it could lead to an increase in cases and potentially overwhelm healthcare systems. Therefore, even though the 0.3% difference may not be enough to completely evade immunity, it is still important to monitor variants closely and take appropriate measures when necessary.

• “The truth is that the SARS-CoV-2 virus has been around for a long time and it is not going to change. It is not mutating into something else.”

  Yeadon’s claims are false. While it is true that the SARS-CoV-2 virus has been around for some time, it is constantly evolving and changing. Scientists have identified several variants of the virus, including one that is 0.3% different from the original strain. These variants can be more contagious or cause more severe symptoms than the original strain, making them a potential threat to public health.

• The pharmaceutical industry is likely making top-up vaccines because they are profitable. Vaccines are a lucrative business, and the industry may be taking advantage of the public’s fear of disease to make more money. Additionally, some people may believe that booster shots are necessary for optimal protection against certain diseases, so the industry may be capitalizing on this belief as well.

Mutations Are Good for Vaccine Business

The push for a third booster shot is concerning, as it could lead to more people being exposed to the risks of the vaccine without any clear evidence that it will provide additional protection against variants. Furthermore, this could create an incentive for vaccine makers to continue to push fear of variants in order to maintain demand for their products. This could also lead to a situation where people are encouraged to get booster shots even when there is no clear evidence that they are necessary or beneficial.

The data from the initial studies suggest that a third dose of the current Pfizer vaccine can significantly increase neutralizing antibody levels. This could be beneficial in providing additional protection against variants of the virus, as well as boosting overall immunity. Pfizer is also researching variant-specific formulations to further improve protection against new variants.

The FDA is currently recommending that people who have received the Pfizer mRNA vaccine get a second dose three weeks after their first dose. This is to ensure that they are fully protected against the virus. However, as more data becomes available, it is possible that the FDA may recommend booster shots at certain intervals in order to maintain protection against the virus.

The company has not yet announced the exact price of the booster shot, but it is expected to be significantly higher than the initial vaccine. Pfizer has said that it will use a tiered pricing system, with different prices for different countries and regions.14 This means that some countries may pay more than others for the booster shot. Additionally, Pfizer has said that it will consider factors such as a country’s ability to pay when setting prices.15

Pfizer’s decision to raise prices on its COVID shot once the pandemic wanes has been met with criticism from some public health experts and patient advocates who argue that raising prices could limit access to the vaccine in poorer countries.16 They argue that if Pfizer charges too much for its booster shots, then people in low-income countries may not be able to afford them and could miss out on important protection against future variants of COVID-19.17

In response to these criticisms, Pfizer has stated that it is committed to making sure its vaccines are accessible and affordable around the world.18 The company also noted that it is working with governments and other organizations to ensure equitable access to its vaccines.19

The COVID-19 vaccine market is expected to reach $26 billion by 2023, according to a report from GlobalData. This includes sales of both the initial two-dose vaccines and booster shots that may be needed in the future. The report also predicts that the global market for COVID-19 vaccines will grow at a compound annual growth rate (CAGR) of 11.2% between 2021 and 2023.

The report also states that the US is expected to remain the largest market for COVID-19 vaccines, with an estimated value of $7.3 billion in 2023. Other countries such as India, China, and Brazil are also expected to contribute significantly to the global vaccine market over the forecast period.

Overall, it is expected that the global demand for COVID-19 vaccines will continue to increase over the next few years as more people get vaccinated and booster shots become available. This could lead to increased profits for vaccine manufacturers as well as improved public health outcomes around the world.

• Pfizer expects a minimum revenue of $15 billion to $30 billion in 2021 alone
• Moderna expects sales of $18.4 billion in 2021; Barclays analyst Gena Wang forecasts the company’s 2022 revenue to be somewhere around $12.2 billion and $11.4 billion in 2023
• Johnson & Johnson expects sales of $10 billion in 2021

Vaccine Treadmill Ahead

The vaccine passport concept is gaining traction as governments and businesses look for ways to ensure that people have been vaccinated against the coronavirus. Vaccine passports could be used to verify a person’s vaccination status, allowing them to travel or access certain services. The idea has sparked debate over privacy concerns and the potential for discrimination against those who are not vaccinated. Supporters of the concept argue that it could help speed up the reopening of economies and allow people to safely resume activities such as international travel. Critics worry that vaccine passports could lead to a two-tiered society in which those without passports are denied access to certain services or opportunities.

• “

  Independent scientists are warning that the use of booster shots to address new variants of the virus could have unintended consequences. The constant development of new variants could lead to a cycle of ever-increasingly virulent and transmissible viruses, making it difficult to keep up with the changing landscape. This could make it more difficult for public health officials to contain the spread of the virus, leading to further outbreaks and increased risk for vulnerable populations.

• Verkerk believes that the best way to prevent variants from becoming more virulent and transmissible is to focus on strengthening the immune system. This can be done through lifestyle changes such as eating a healthy diet, getting enough sleep, exercising regularly, and managing stress levels. Additionally, he recommends taking natural supplements such as vitamins C and D, zinc, selenium, and probiotics to support the immune system. He also suggests avoiding activities that could increase the risk of infection such as large gatherings or travel.

He urged the WHO to consider the potential risks of such a campaign and to focus on more targeted approaches that would reduce the risk of new mutations.

• “There can be no doubt that continued mass vaccination campaigns will enable new, more infectious viral variants to become increasingly dominant and ultimately result in a dramatic incline in new cases despite enhanced vaccine coverage rates. There can be no doubt either that this situation will soon lead to complete resistance of circulating variants to the current vaccines,” Bossche wrote.¹⁹

Will COVID-19 Shots Save Lives? Probably Not

The trials are designed to measure the efficacy of the vaccine in preventing symptomatic disease, but not whether it will reduce mortality or hospitalizations. This means that even if a vaccine is approved, it may not be effective in reducing the number of deaths from COVID-19.

Dr. Cunningham’s response highlighted several studies that showed vaccines were not effective in reducing mortality rates, including a 1972 study of the measles vaccine in India which found that mortality rates actually increased after the introduction of the vaccine. He also cited a 1985 study of the diphtheria-tetanus-pertussis (DTP) vaccine in Senegal which showed no significant reduction in mortality rates despite an increase in vaccination coverage. Finally, he noted a 1997 study of the DTP vaccine in Guinea-Bissau which found that mortality rates were higher among vaccinated children than those who had not been vaccinated.

Overall, Dr. Cunningham’s response suggested that vaccines may not be as effective as previously thought and may even have a net negative effect on mortality rates. He concluded by calling for further research into the efficacy of vaccines and their potential risks and benefits.

“The CDC has a long history of exaggerating the severity of illnesses in order to increase vaccination rates. This is especially true for influenza, where the CDC has been caught inflating mortality numbers by as much as 1000%. It appears that the same tactics are being used with COVID-19, and it is likely that the actual death rate from COVID-19 is much lower than what is being reported.”

• The study found that the risk of all-cause mortality was higher in elderly men who received influenza vaccines compared to those who did not. The risk was highest during A/H3N2-predominant seasons, with an increase of 16.6%. This suggests that influenza vaccines may be less effective in protecting elderly men from all-cause mortality during these seasons. Further research is needed to understand why this increased risk exists and how it can be minimized.
• The history of influenza vaccines should serve as a cautionary tale for the development and implementation of Covid-19 vaccines. We must be careful to ensure that any vaccine is safe and effective before it is widely distributed, and that we have a clear understanding of the potential risks and benefits associated with its use. Additionally, we must be mindful of the potential for unintended consequences, such as increased risk of other illnesses or conditions due to changes in immunity caused by the vaccine. Finally, we must ensure that any vaccine is accessible to all who need it, regardless of their economic or social status.
• This idea is important to consider, especially in light of the fact that the vaccine effectiveness studies often fail to take into account the potential risks associated with receiving a flu vaccine. Vaccines can provide some protection against seasonal flu, but they are not without risk. It is important to weigh the potential benefits of vaccination against the potential risks before making a decision about whether or not to get vaccinated. Additionally, it is important to recognize that there may be other ways to protect oneself from seasonal flu, such as good hygiene practices and avoiding contact with people who are ill.

Natural Selection Will Win

We must continue to rely on science-based evidence and research to inform our decisions.

This is a great thing, as it will help us to make more informed decisions about our health and the health of those around us.

The truth is out there, and it’s getting harder and harder for the quacks to hide it. People are starting to realize that the vaccine frauds have been going on for decades, and that they are only getting worse. The lies and propaganda are becoming more obvious, and the censorship is becoming more oppressive. It’s time for people to stand up and demand real answers from those in power.

“Vaccines can drive the evolution of viruses in two ways. First, they can select for variants that are better at evading the immune system. Second, they can select for variants that are better at infecting vaccinated individuals.”

The New York Times adds:24

“Vaccines can also drive the evolution of viruses by selecting for variants that are better able to evade the vaccine-induced immunity. This is known as antigenic drift, and it is a natural consequence of vaccinating large populations against a virus.”

• This research suggests that the use of vaccines can lead to changes in pathogen populations, with some species becoming more dominant as a result. This could have implications for public health, as it may be necessary to adjust vaccination strategies in order to keep up with the changing dynamics of pathogen populations. Additionally, this research highlights the importance of continued monitoring and surveillance of pathogen populations in order to ensure that our vaccination strategies remain effective.
• Yes, this is true. Vaccines work by introducing a weakened or inactive form of a pathogen into the body, which stimulates the immune system to produce antibodies that can recognize and fight off the pathogen if it is encountered in the future. However, some pathogens are able to mutate and change their shape or structure, making them unrecognizable to the antibodies produced by the vaccine. This can make it more difficult for the immune system to recognize and fight off these mutated forms of the pathogen, leading to an increased prevalence of certain genetic variants of pathogens.

• They have long known that pathogens can evolve quickly in response to environmental pressures, such as the introduction of a vaccine. As a result, some pathogens may become more virulent or resistant to treatments. For example, when a vaccine is introduced for a particular strain of influenza virus, the virus may mutate and become more dangerous than before. This phenomenon is known as “antigenic drift.”

• This is known as vaccine escape. Vaccine escape can occur in several ways, including mutations that reduce the effectiveness of the vaccine, or changes in the pathogen’s surface proteins that make it unrecognizable to the immune system. Vaccine escape can also occur when a pathogen develops resistance to a particular drug used to treat it. In this case, the drug-resistant strain will become more common in an immunized population.

The European Union has adopted a number of regulations that have had a significant impact on the natural health industry. These include the Traditional Herbal Medicinal Products Directive (THMPD), which requires herbal products to be registered and approved before they can be sold in the EU, and the Food Supplements Directive (FSD), which sets maximum levels for vitamins and minerals in food supplements. Both of these directives have been criticized by many in the natural health industry, who argue that they are overly restrictive and limit consumer access to safe and effective natural health products.

• The answer to this question depends on the specific country and region in which the mutants are present. In some countries, such as the United Kingdom, the frequency of mutant strains has been increasing due to increased travel and contact between people from different parts of the world. In other countries, such as the United States, mutations have been declining due to widespread vaccination efforts. It is important to note that even if a particular strain is declining in one area, it may still be increasing in another area. Therefore, it is important to monitor mutant strains on a global scale in order to understand their overall prevalence and potential impact.
• The best way to reduce the chances of mutation is to reduce the spread of infection. Vaccination is one way to do this, but it is not the only way. We must also continue to practice social distancing, wear masks, and practice good hygiene. Additionally, we should be vigilant in testing for new variants and monitoring their spread so that we can take action quickly if needed. Finally, we should continue to invest in research and development of new treatments and vaccines so that we can stay ahead of any potential mutations.
• If variants become more transmissible and virulent, it could lead to a rapid spread of the virus, resulting in a much higher number of cases and deaths. It could also make existing treatments and vaccines less effective, as the virus evolves to become resistant to them. This could lead to an even greater strain on healthcare systems around the world, as well as an increased risk of long-term health complications for those who contract the virus. In addition, if these variants become widespread, it could be difficult to contain them due to their increased transmissibility and virulence.
• We need to focus on developing better treatments and therapies that can help people recover from the virus, rather than just trying to outsmart it. This could include developing drugs that target specific pathways in the virus, or using gene therapy to modify the body’s immune response to the virus. Additionally, we should focus on improving public health measures such as social distancing, mask-wearing, and contact tracing to reduce transmission of the virus.

• Herd immunity is a concept that suggests that when a large portion of the population is immune to a virus, it will be difficult for the virus to spread and infect others. This means that even those who are not vaccinated can still benefit from the protection of herd immunity.

• This highlights the importance of understanding the complexities of herd immunity in order to effectively manage and control infectious diseases.

• Vaccinated people are still at risk of infection from mutant variants of viruses, as the antigen-specific antibodies produced by the vaccine may not be able to bind firmly enough to the virus particles. This means that natural antibodies may not be able to compete with the virus particles, allowing them to infect vaccinated individuals. As a result, vaccinated people may have less cross-immunity to mutant variants that are more infectious, and this can lead to a wave of infectivity continuing.